Clinical trials
Phase 2 Leukemia, Biphenotypic, Acute trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Completed | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Guangdong Second Provincial General Hospital | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Sheng-Li Xue, MD | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
| yuejun Liu | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Biphenotypic, Acute | 5 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Philadelphia Chromosome | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Pyloric Stenosis, Hypertrophic | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.